Profil
Ozgur Tuncer is associated with Stablepharma Ltd.
as the Chief Executive Officer & Executive Director.
He is also currently working as an Investment Partner at Ascension Ventures Ltd.
Postes actifs de Ozgur Tuncer
| Sociétés | Poste | Début |
|---|---|---|
Ascension Ventures Ltd.
 Ascension Ventures Ltd. Investment ManagersFinance Ascension Ventures Ltd (Ascension Ventures) is a venture capital firm founded by Jean de Fougerolles and the firm headquartered in London. | Private Equity Investor | 01/01/2021 |
Stablepharma Ltd.
 Stablepharma Ltd. Pharmaceuticals: MajorHealth Technology Stablepharma Ltd. is a British company that specializes in developing fridge-free vaccines to improve patient access to safe and effective treatment. The company's science team is based at Stablepharma's R&D center in Qube Technology Park, which is located 20 miles from an international airport. The company is based in Bath, UK. The team is led by Dr. Arcadio Garcia de Castro, the Chief Scientific Officer, and supported by Juana de la Torres, Senior R&D Manager, and the wider team. The company continues their work validating the high-temperature stability of vaccines. The company was founded in 2012 by Bruce Roser, who identified and patented the process of using trehalose to achieve a state of 'suspended animation' in a sugar glass, to thermally stabilize a range of vaccines. The CEO is Ozgur Tuncer. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Ascension Ventures Ltd.
Ascension Ventures Ltd. Investment ManagersFinance Ascension Ventures Ltd (Ascension Ventures) is a venture capital firm founded by Jean de Fougerolles and the firm headquartered in London. | Finance |
Stablepharma Ltd.
Stablepharma Ltd. Pharmaceuticals: MajorHealth Technology Stablepharma Ltd. is a British company that specializes in developing fridge-free vaccines to improve patient access to safe and effective treatment. The company's science team is based at Stablepharma's R&D center in Qube Technology Park, which is located 20 miles from an international airport. The company is based in Bath, UK. The team is led by Dr. Arcadio Garcia de Castro, the Chief Scientific Officer, and supported by Juana de la Torres, Senior R&D Manager, and the wider team. The company continues their work validating the high-temperature stability of vaccines. The company was founded in 2012 by Bruce Roser, who identified and patented the process of using trehalose to achieve a state of 'suspended animation' in a sugar glass, to thermally stabilize a range of vaccines. The CEO is Ozgur Tuncer. | Health Technology |
